These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 5094375)

  • 1. [Compounds of 4-aminophenazone with piperidine-4-phenyl carbonic acids].
    Dick J; Maurer A; Dick PW
    Pharmazie; 1971 Jul; 26(7):439-40. PubMed ID: 5094375
    [No Abstract]   [Full Text] [Related]  

  • 2. Design and synthesis of 4-phenyl piperidine compounds targeting the mu receptor.
    Chen Z; Davies E; Miller WS; Shan S; Valenzano KJ; Kyle DJ
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5275-9. PubMed ID: 15454210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Synthesis of 4-acyl-4-(3-chlorophenyl)-1-dialkylaminopropyopropyl)-piperidines. II. Synthesis of 4-acyl-4-(3-chlorophenyl)-1-(3-dialkylaminopropyl)-piperidines].
    Rylski L; Pac-Pomarnacka E
    Acta Pol Pharm; 1976; 33(2):163-7. PubMed ID: 937019
    [No Abstract]   [Full Text] [Related]  

  • 4. [Search for anticholinergic agents. IV. Synthesis of 4-piperidinemethyl-1,3-dioxolane derivatives].
    Woliński J; Czerwińska A
    Acta Pol Pharm; 1977; 34(2):143-7. PubMed ID: 868540
    [No Abstract]   [Full Text] [Related]  

  • 5. [Synthesis of some 1-(3-(dialkylamino)-propyl)-4-acyl-4-phenyl-piperidines. IV. Derivatives of 1-alkyl-4-butyryl-4-phenylpiperidine, 1-alkyl-4-valeryl-piperidine and 1-alkyl-4-benzoyl-4-phenylpiperidine].
    Rylski L; Gajewski F; Kurowski J; Markiewicz M
    Acta Pol Pharm; 1971; 28(4):345-52. PubMed ID: 5145784
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis and biological evaluation of phenyl piperidine derivatives as CCR2 antagonists.
    Xia M; Hou C; Pollack S; Brackley J; DeMong D; Pan M; Singer M; Matheis M; Olini G; Cavender D; Wachter M
    Bioorg Med Chem Lett; 2007 Nov; 17(21):5964-8. PubMed ID: 17869105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies on aromatic basic ethers with antispasmodic activity. IV. Syntheses and anticholinergic activities of methylsubstituted phenyl 1-phenyl-3-piperidinopropyl ethers (author's transl)].
    Yoshida A; Morita M; Ogawa S
    Yakugaku Zasshi; 1973 Sep; 93(9):1144-53. PubMed ID: 4797570
    [No Abstract]   [Full Text] [Related]  

  • 8. A synthetic approach to the skeleton of histrionicotoxin.
    Tufariello JJ; Trybulski EJ
    J Org Chem; 1974 Nov; 39(23):3378-84. PubMed ID: 4427184
    [No Abstract]   [Full Text] [Related]  

  • 9. New classes of antimuscarinic agents endowed with selective antispasmodic properties. 1-Arylsulfonyl pyrrolidin-2-ones and 2-thiones, 1-arylsulfonyl piperidin-2-ones and 2-thiones and 1-arylsulfonyl hexahydro-2H-azepin-2-one.
    Toja E; Parini C; Bonetti C; Hunt P; Fortin M; Barzaghi F; Cesana R; Maggioni A; Nencioni A; Galliani G
    Arzneimittelforschung; 1994 Apr; 44(4):501-9. PubMed ID: 8011004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of cis-(6-benzhydrylpiperidin-3-yl)benzylamine analogues with monoamine transporters: structure-activity relationship study of structurally constrained 3,6-disubstituted piperidine analogues of (2,2-diphenylethyl)-[1-(4-fluorobenzyl)piperidin-4-ylmethyl]amine.
    Kolhatkar RB; Ghorai SK; George C; Reith ME; Dutta AK
    J Med Chem; 2003 May; 46(11):2205-15. PubMed ID: 12747792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymmetric carbon-carbon bond-forming reaction at the 2-position of a piperidine skeleton.
    Kanda Y; Onomura O; Maki T; Matsumura Y
    Chirality; 2003 Jan; 15(1):89-94. PubMed ID: 12467049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and structure-activity relationships of piperidine-based melanin-concentrating hormone receptor 1 antagonists.
    Wu WL; Burnett DA; Spring R; Qiang L; Sasikumar TK; Domalski MS; Greenlee WJ; O'Neill K; Hawes BE
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3668-73. PubMed ID: 16690312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological and histopathological aspects of 1-methyl-4-phenyl-4-hydroxy-piperidine (MPIP).
    Bruno S; DeLaurentis N; Milillo MA; Tantillo G; Perillo A
    Boll Chim Farm; 1996 Apr; 135(4):236-8. PubMed ID: 8913053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [2-(4-Phenyl-4-piperidinyl)ethyl]amine based CCR5 antagonists: derivatizations at the N-terminal of the piperidine ring.
    Duan M; Aquino C; Ferris R; Kazmierski WM; Kenakin T; Koble C; Wheelan P; Watson C; Youngman M
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1610-3. PubMed ID: 19233649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of piperidine farnesyltransferase inhibitors with reduced glucuronidation potential.
    Tanaka R; Rubio A; Harn NK; Gernert D; Grese TA; Eishima J; Hara M; Yoda N; Ohashi R; Kuwabara T; Soga S; Akinaga S; Nara S; Kanda Y
    Bioorg Med Chem; 2007 Feb; 15(3):1363-82. PubMed ID: 17127066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of an opioid kappa receptor subtype-selective N-substituent for (+)-(3R,4R)-dimethyl-4-(3-hydroxyphenyl)piperidine.
    Thomas JB; Fall MJ; Cooper JB; Rothman RB; Mascarella SW; Xu H; Partilla JS; Dersch CM; McCullough KB; Cantrell BE; Zimmerman DM; Carroll FI
    J Med Chem; 1998 Dec; 41(26):5188-97. PubMed ID: 9857089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Divergent asymmetric synthesis of 3,5-disubstituted piperidines.
    Olofsson B; Bogár K; Fransson AB; Bäckvall JE
    J Org Chem; 2006 Oct; 71(21):8256-60. PubMed ID: 17025320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 1: Discovery and SAR study of 4-pyrazolylpiperidine side chains.
    Shen DM; Shu M; Mills SG; Chapman KT; Malkowitz L; Springer MS; Gould SL; DeMartino JA; Siciliano SJ; Kwei GY; Carella A; Carver G; Holmes K; Schleif WA; Danzeisen R; Hazuda D; Kessler J; Lineberger J; Miller MD; Emini EA
    Bioorg Med Chem Lett; 2004 Feb; 14(4):935-9. PubMed ID: 15012997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-heteroaryl-2-phenyl-3-(benzyloxy)piperidines: a novel class of potent orally active human NK1 antagonists.
    Ladduwahetty T; Baker R; Cascieri MA; Chambers MS; Haworth K; Keown LE; MacIntyre DE; Metzger JM; Owen S; Rycroft W; Sadowski S; Seward EM; Shepheard SL; Swain CJ; Tattersall FD; Watt AP; Williamson DW; Hargreaves RJ
    J Med Chem; 1996 Jul; 39(15):2907-14. PubMed ID: 8709125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syntheses and structure-activity relationship studies of piperidine-substituted quinolones as nonpeptide gonadotropin releasing hormone antagonists.
    Jiang J; DeVita RJ; Goulet MT; Wyvratt MJ; Lo JL; Ren N; Yudkovitz JB; Cui J; Yang YT; Cheng K; Rohrer SP
    Bioorg Med Chem Lett; 2004 Apr; 14(7):1795-8. PubMed ID: 15026074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.